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Autosomal dominant polycystic kidney disease in childhood: A longi.
tudinal study. One hundred fifty—four children aged eighteen years or
younger from 83 families with autosomal—dominant polycystic kidney
disease were studied by ultrasonography or excretory urography.
Twenty—three children had bilateral renal involvement with at least five
cysts (ADPKD), 28 children were classified as suspicious (SADPKD),
and 103 children had no renal involvement (NADPKD) detected by
ultrasound. Seventy—four percent of the ADPKD children had signs or
symptoms compatible with the diagnosis of ADPKD, compared to 34%
of the NADPKD and 36% of the SADPKD children (both P < 0.05).
Three of the 23 ADPKD children had elevated serum creatinines at the
time of diagnosis, while all of the NADPKD and SADPKD children had
normal renal function. Renal area by ultrasonography (width x depth)
was greater among the ADPKD children compared to the SADPKD and
NADPKD groups (P < 0.05). On follow—up 30 of the 37 NADPKD
children remained NADPKD, three were reclassified as SADPKD, and
four progressed to ADPKD after 18 years of age. All of the NADPKD
children had normal renal function on follow—up. Overall, 14 children
had suspicious ultrasounds at some point with follow—up ultrasonogra-
phy and ten (71%) progressed to ADPKD. All SADPKD children
maintained normal renal function. Eight of 18 ADPKD children had
progression of the disease manifested by development of hypertension
and/or decreased renal function. Three children progressed to end—
stage renal disease. Five ADPKD children were diagnosed before one
year of age, two of them via prenatal ultrasonography. One fetus was
aborted after documentation of oligohydramnios. Two of these children
required renal replacement therapy at age three and 15 years, two are
stable at age four and five years of age. We conclude that those children
diagnosed as ADPKD under one year of age may have a deterioration
in renal function early in life; however, those identified in childhood by
screening may have a benign early course. The finding of a single renal
cyst in a child in an ADPKD family should be considered suggestive of
the disease. With history, physical examination, and ultrasonography
ADPKD may be identifiable in as many as two—thirds of affected
subjects during childhood, thus permitting early genetic counseling and
medical attention.
Autosomal—dominant polycystic kidney disease (ADPKD) is
one of the most common genetic diseases, with prevalence
figures varying from one in 220 to one in 1,100 autopsies [1]. It
is responsible for ten percent of all documented end—stage renal
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disease [2]. The clinical diagnosis is usually made between the
third and fourth decades of life. However, ADPKD has been
identifed in utero by ultrasonography and as late as 96 years of
age by autopsy [3]. The occurrence of ADPKD in children has
been poorly documented, because the disease mimics autoso-
mal—recessive polycystic kidney disease and family histories
are often inadequate. However, since 1946 approximately
seventy—nine children have been reported in the literature with
early manifestations of ADPKD [4—24]. Despite these multiple
case reports verifying the presence of ADPKD in children,
there are no large prospective studies and, therefore, little
knowledge about the long term course of the disease in these
individuals.
Ultrasonography has made it possible to prospectively study
and follow children in ADPKD families noninvasively. Using
this technique, we examined a large group of children from
ADPKD families to identify children with early onset of the
disease and to provide insight into the course of their disease.
Methods
All children enrolled in this study were members of families
with documented ADPKD. Diagnosis of family members was
confirmed via ultrasonography, excretory urography, findings
at nephrectomy or autopsy, and by a pattern of autosomal
dominant inheritance. Children were seen as part of a volun-
tary, prospective—family screening study or were referred for
signs and/or symptoms of ADPKD. All children had a routine
history and physical examination; three had excretory urogra-
phy and the remainder had ultrasonography. The majority of
children had blood obtained for blood urea nitrogen and creat-
mine, and had a urinalysis performed. Children were consid-
ered negative for ADPKD (NADPKD) if no cysts were seen on
the ultrasonography. Children were classified as suspicious for
ADPKD (SADPKD) when fewer than five cysts were present,
or if cysts were unilateral, or an inhomogeneous echo pattern
was present which suggested very small cysts. ADPKD was
diagnosed by ultrasonography or excretory urography when
cysts were bilateral and totaled five or more in number.
Children initially classified as NADPKD or SADPKD who
developed ADPKD by age 18 were included in the ADPKD
group only. Informed consent was obtained from parents of
children involved in this study.
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Table 1. Epidemiology of ADPKD in childhood
Age of
N Male Female
% Affected classification
years mean
+ SE
Classification
via family
screening, %
Patients with
symptoms
and/or signs, %Mother Father
NADPKD 103 51 52 34 25 10.3 0.4 100 34
SADPKD 28 14 14 18 36 12.4 0.7 96 36
ADPKD 23 13 10 39 52 10.2 1.4 70 74b
a P < 0.01, SADPKD + ADPKD vs. NADPKDb P < 0.05, vs. NADPKD or SADPKD
Table 2. Signs and symptoms in children at presentation
NA
N
DPKD
= 103
%
SADPKD
N=28
%
AD
N
PKD
=23
%
Abdominal or flank pain 11 7 22
Headaches 8 7 13
Urinary tract infections 6 21 13
Gross hematuria 3 4 26
Proteinuria 1 0 9
Hypertension (by history) 5 7 22
Palpable abdominal mass 0 0 22"
Hernias 1 4 22
a P < 0.005, vs. NADPKDb P < 0.05, vs. NADPKD or SADPKD
A majority of the data analysis was accompanied using
Contingency Table analysis methods (Chi—square Test). Some-
times, due to small sample sizes and expected frequencies,
Fisher's Exact Test was used. One—way ANOVA procedures
were used to compare the means of continuous variables among
the different groups. Multiple comparisons procedures (specif-
ically Student Newman—Keuls) were used to do the pairwise
comparisons of the means.
Results
One hundred fifty—four children from 83 families were stud-
ied. The age of initial ultrasound ranged from 22 weeks gesta-
tion to 18 years of age. One—hundred—three children were
classified at NADPKD, 28 as SADPKD, and 23 as ADPKD
(Table 1). Although all children were members of ADPKD
families, not all children studied had a parent already known to
have ADPKD. Several of the parents were diagnosed as having
ADPKD after an ultrasound was positive in the child. None of
the children was known to be a product of a consanguineous
marriage or to have both parents affected. In the 103 NADPKD
children, 35 had an affected mother, 26 an affected father, and
36 had another affected family member (such as a grandparent).
In the 28 SADPKD patients, five had an affected mother, 10 an
affected father, and 13 had another affected member. There was
an even distribution of males and females in all three groups
(NS). In the 23 ADPKD patients, nine had an affected mother,
12 and affected father, and two had another affected member.
Therefore, a child classified as SADPKD or ADPKD was more
likely to have an affected father than a mother (P < 0.01). This
was not true in the NADPKD group. The mean age of children
in the three groups at the time of the diagnostic ultrasound
study was not different (10.3 0.4 years in the NADPKD
group, 12.4 0.7 years in the SADPKD group, and 10.2 1.4
years in the ADPKD group, NS).
All of the NADPKD children were identified through family
screening, but at the time of study 34% had symptoms or signs
compatible with ADPKD, including flank or abdominal pain,
headaches, urinary tract infections, hematuria, hypertension
(greater than 150/90 or 95th percentile for age), or proteinuna
(Table 2). All but one of the SADPKD group were identified
through family screening, and 36% had symptoms or signs
compatible with ADPKD at the time of study. Seven of the 23
children with ADPKD were studied because of a history of
hypertension, proteinuria, hematuria, or palpable abdominal
masses; the remaining 16 children were identified through
family screening. Children with ADPKD were more likely to
have signs or symptoms compatible with ADPKD than the
NADPKD (74% vs. 34%, P < 0.01) or SADPKD groups (74%
vs. 36%; P < 0.05). There was no difference in prevalence of
flank or abdominal pain, headaches, proteinuria, or urinary
tract infections among the three groups (NS). However, the
ADPKD children were more likely to have a history of gross
hematuria or hypertension compared to the NADPKD group (P
< 0.05), and were more likely to have palpable abdominal
masses compared to the NADPKD (P < 0.01) and SADPKD
(P <0.05) groups.
Five percent of the NADPKD children had elevated blood
pressures at the time of diagnosis. Seven percent of the
SADPKD children had a history of hypertension, although their
blood pressures were normal at initial visit. In contrast, 22
percent of the ADPKD children had hypertension at the time of
diagnosis (both P < 0.05).
Hernias were present or had been present and surgically
repaired in five children with ADPKD: inguinal (2), femoral (1),
and umbilical (2). One child with SADPKD had an inguinal
hernia; one NADPKD child had an umbilical hernia and one
NADPKD child had inguinal hernias. Thus five of 23 ADPKD
children had hernias compared to two of 101 children with
NADPKD (P < 0.01).
Urinalyses were performed in 84 NADPKD, 28 SADPKD,
and 20 ADPKD children at or before the time of diagnosis
(Table 3). Those children with ADPKD were more likely to
have an abnormal urinalysis than the NADPKD (90% vs. 42%,
P < 0.001) or SADPKD children (90% vs. 54%, P < 0.005).
When elevated separately, however, there was no difference in
the incidence of pyuria, hematuria, or proteinuria among the
three groups (NS).
All of the NADPKD and SADPKD children had normal renal
function at the time of diagnosis, as defined by a normal serum
creatinine for age. Three ADPKD children had elevated serum
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Table 3. Urinalysis data at presentation
NADPKD
N=84
%
SADPN=
%
KD
28
AD
N
PKD
=20
%
Abnormal 42 54 90a
I + proteinuria or greater 2 14 14
1—5 wbc/hpf 31 32 40
>5 wbc/hpf 7 14 5
1—5 rbc/hpf 11 21 14
>5 rbc/hpf 2 0 5
a P < 0.005, vs. NADPKD or SADPKD
creatinines at the time of diagnosis. The average blood urea
nitrogen at the time of diagnosis was not different among the
three groups (12.9 0.3 mg/dl in the NADPKD group,
12.7 0.6 mg!dl in the SADPKD group, and 14.6 1.4 mg/dl
in the ADPKD group, NS). However, the mean serum creati-
nine was higher in the ADPKD group compared to both the
SADPKD and NADPKD groups: 0.94 0.08 mgldl in the
ADPKD group, 0.80 0.03 mgldl in the SADPKD group, and
0.72 0.02 mgldl in the NADPKD group (P <0.05).
The renal area was calculated by multiplying width (cm) by
depth (cm) as measured by ultrasonography. The renal area was
greater among the ADPKD children as compared to the
SADPKD and NADPKD children: 36.4 3.8 cm2 in the
ADPKD group, 23.2 1.6 cm2 in the SADPKD group, and
22.0 0.8 cm2 in the NADPKD group (P < 0.05).
Of those children who had more than one visit (Table 4),
length of follow-up was also not different in the three groups:
11.2 1.2 years in the NADPKD group (N = 35), 6.8 1.3
years in the SADPKD group (N 12), and 7.6 1.4 years in
the ADPKD group (N = 19).
In the NADPKD group 30 of 37 remained NADPKD, three
were reclassified as SADPKD, and four progressed to ADPKD
after 18 years of age. Two of these four patients were diagnosed
as ADPKD at the ages of 31 and 33, at which time they had no
symptoms, normal blood pressures, normal urinalyses, and
normal serum creatinine concentrations. The third patient had
normal ultrasound studies at age 15, 16, and 23 years; a fourth
ultrasound at 31 years revealed multiple bilateral cysts. This
individual had a history of flank and abdominal pain and pyuria;
renal function and blood pressure are normal. The fourth
patient had a normal ultrasound at age 12 years (NADPKD),
one cyst in each kidney at age 25 years (SADPKD), and
multiple cysts bilaterally at age 32 years (ADPKD). She has a
history of urinary tract infections with pyuria; blood pressure
and renal function are normal. Only one NADPKD child
developed hypertension at a later age; this was a 30—year—old
male who remained NADPKD. All of the NADPKD children
had normal, serum creatinine concentrations at follow—up.
Eight of the 28 SADPKD children had follow—up ultrasonog-
raphy: five had an increase in cyst number with four progressing
to ADPKD, two remained SADPKD, and two children who
were initially considered to have a single cyst were reclassified
as NADPKD because subsequent ultrasonography did not
reveal the presence of cysts. One SADPKD child developed
hypertension at the age of 15; all SADPKD children maintained
normal renal function. In addition to these eight children with
SADPKD, there were six additional subjects who at some point
Table 4. Follow-up data on children in ADPKD families
NADPKD SADPKD ADPKD
N 37 12 19
Years of follow-up
mean + SE 11.2 1.2 6.8 1.3 7.6 1.4
Reclassified as NADPKD
after age 18 NA 2 0
Reclassified as SADPKD
after age 18 3 NA 0
Reclassified as ADPKD
after age 18 4 4 NA
Development of hypertension 1 1 6
Development of azotemia 0 0 4
NA = not applicable
had an ultrasound interpreted as SADPKD and later had
follow—up ultrasonography. These six additional subjects in-
cluded five ADPKD children who initially had suspicious
ultrasounds and one NADPKD child who was classified as
SADPKD at age 25 and ADPKD at age 32. Thus, ten of the 14
(71%) subjects who at some point had suspicious ultrasonogra-
phy progressed to ADPKD, two remained SADPKD, and two
were reclassified as NADPKD.
Eighteen ADPKD children were seen in follow—up. Of 11
children with serial ultrasonography after diagnosis, 10 had an
increase in cyst number or size. Eight had progression of the
disease manifested by development of hypertension alone
(N = 4), decreased renal function (N = 2), or both hyperten-
sion and azotemia (N = 2). Three children progressed to
end—stage renal disease at the ages of three, 15, and 39 years of
age; the first two of these patients were diagnosed in the first
year of life. One of these three children required numerous
blood transfusions for repeated episodes of gross hematuria.
Individual data on the five children documented to have
ADPKD before one year of age are displayed in Table 5. Two
were diagnosed via prenatal ultrasonography, and one fetus was
aborted after documentation of oligohydramnios. Patients num-
bered 3 and 4 are siblings. In each case the affected parent had
normal renal function into the third decade of life.
Discussion
In 1957 Dalgaard published the classic study on ADPKD
determining the autosomal dominant pattern of inheritance and
describing the clinical syndrome [3]. The study, however,
provided little information on the disease in children because
the majority of the subjects were uremic adults. Dalgaard stated
that disease patterns were similar within families, suggesting
that children would not be likely to have earlier involvement
than their parents [3]. Two other factors contributed to the
difficulty in establishing the diagnosis of ADPKD in children:
the clinical impression that cystic disease in children repre-
sented autosomal recessive PKD and the lack of diagnostic
technique sufficiently sensitive to detect small cysts.
Prior to the present study, seventy—nine cases of ADPKD
have been reported in individuals less than 18 years of age
[4—26], and the largest individual series describes eleven chil-
dren [26]. These reports as well as the present study document
that the ADPKD gene defect can be manifested early in life with
development of renal cysts. Although many children previously
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Table 5. Data on children with ADPKD diagnosed before one year of age
Relative with
documented
disease
Status of
affected parent
Method of
diagnosis in
child
Signs of
ADPKD in child
Years of
follow—up Outcome
#1 Mother Age 24
Hypertension
Ultrasound Abdominal mass 5 ESRD, transplant
age 3.5 year
#2 Father Diagnosed age 40, died
age 55 on dialysis
Intravenous
pyelogram
Abdominal mass 15 ESRD age 15 on
dialysis
#3 M,ttier Age 34
Hypertension, normal
renal function
Prenatal ultra-
sound
Enlarged kidneys with
one cyst
5 Stable with mild
hypertension
#4 Mother Same as #3 Prenatal ultra-
sound
Enlarged kidneys and
oligohydramnios
— Abortion
#5 Mother Age 33
Normal blood pressure
and renal function
Ultrasound Abdominal mass 4 Stable
ESRD, End—stage renal disease
reported in the literature died at a young age, there is no
previous longitudinal data available on children with ADPKD to
substantiate this ominous prognosis. In fact, the present results
suggest that the natural history of childhood ADPKD may not
have such a poor prognosis.
In the present study we follow a large group of children to
gain insight into the course of ADPKD diagnosed in childhood.
The results demonstrated that children classified as SADPKD
or ADPKD were more likely to have an affected father than
mother. This may be similar to Huntington's disease, in which
children of an affected father appear to have earlier onset of
disease than children of an affected mother [27]. In Hunting-
ton's disease, it has been postulated that the ovum has a
cytoplasmic protective factor that sperm lacks, thus accounting
for this observation [27]. However, of the five children in the
present study diagnosed within the first year of life, four had
affected mothers and one an affected father.
Ultrasonography has been a useful tool in identifying renal
cysts early in life [261. It should be emphasized, however, that
the finding of cysts in a neonate or child does not establish the
diagnosis of ADPKD, since in the fetus or the very young child
the diagnosis of autosomal—recessive polycystic kidney disease
(ARPKD) needs to be considered. The presence of ADPKD in
a parent is the most helpful data in establishing ADPKD rather
than ARPKD. Also a number of children who have been
referred with cystic—appearing renal ultrasounds as infants have
simply had luscent areas in the medullary pyramids which can
be characteristic of kidneys early in life. Several children
originally classified on grey scale ultrasound as ADPKD are
negative by real time ultrasound. In the present study definite
cysts were detected by ultrasonography in 45 children aged 18
years of age or younger, with two patients diagnosed in utero.
Conversely, it should be emphasized that a negative ultrasound
during childhood does not ensure that a child will remain
normal, as evidenced by one patient who had three ultrasound
studies interpreted as normal by 23 years and multiple cysts
were found on the fourth study at age 31 years.
The diagnosis of SADPKD in the present study was made if
the ultrasound revealed unilateral cysts, fewer than five cysts
bilaterally, or an inhomogenous pattern suggestive of cysts.
This group was arbitrarily defined in an attempt to differentiate
patients with simple cysts from the ADPKD group. However,
while simple renal cysts are common in adults [28], the preva-
lence in children is less than four percent [29, 30]. These data
suggest, therefore, that any cyst in the child at risk for ADPKD
probably indicates the presence of the gene defect. In previous
studies the presence of one cyst was considered to be evidence
of the disease, although no follow—up was available to substan-
tiate this possibility [25, 26]. In support of this interpretation,
seventy—one percent of the children in the present study who
had suspicious ultrasonography at some point and underwent
follow—up ultrasonography progressed to ADPKD. Therefore,
the presence of any renal cyst in a child in an affected family is
indeed very suggestive of the disease. Such children warrant
follow—up with urinalysis and blood pressure monitoring on at
least a yearly basis. Repeat ultrasonography should be per-
formed every two to three years to assess the progression of the
disease.
Gross hematuria, hypertension, a palpable abdominal mass,
or an abnormal urinalysis was present in greater than 90 percent
of children who had the definite diagnosis of ADPKD by
ultrasonography. Thus, children of ADPKD families should be
followed annually and the presence of any of these findings
would provide an indication for ultrasonography, a more sen-
sitive and less—invasive diagnostic approach than excretory
urography [31]. Although computerized axial tomography may
be slightly more sensitive than ultrasonography in diagnosing
ADPKD [32], it is associated with radiation exposure and
contrast and may require sedation in young children. To date it
is not known whether magnetic resonance imaging, which is
more expensive, will provide a more sensitive means of diag-
nosing ADPKD in childhood.
Only ten percent of the ADPKD children, 46% of the
SADPKD children and 48% of the NADPKD children had a
normal urinalysis. It is not clear why the NADPKD and
SADPKD children had such a significant incidence of abnormal
urinalyses. This may reflect the strict criteria used, in that the
presence of one to five red blood cells or white blood cells per
high power field was considered abnormal. Nevertheless, the
presence of an abnormal urinalysis in an NADPKD or
SADPKD child did not appear to be helpful in predicting who
would progress to ADPKD in our period of follow—up. Longer
term follow—up, however, may alter this observation.
Two of the four children diagnosed as ADPKD in the first
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year of life progressed to end—stage renal disease during child-
hood, suggesting that the diagnosis of the disease in the
neonatal period has a more ominous prognosis and warrants
closer follow—up. However, all of the SADPKD and eighty
percent of the ADPKD children seen in follow—up maintained
normal renal function, indicating that in contrast to previous
suggestions, the diagnosis of ADPKD in children by screening
after the neonatal period appears to be generally associated
with a benign early course.
Of 154 children in the present study from ADPKD families,
77 patients (50%) might be expected to ultimately develop
ADPKD. Of these children 23 of 154 (15%) were definitely
diagnosed as ADPKD, and 26 of 154 (17%), excluding the two
SADPKD children who were reclassified as NADPKD, were
classified as suspicious. If all of these 49 children (32%) with
ADPKD and SADPKD are considered to have inherited the
gene, and this seems quite likely based on the follow—up studies
thus far, then the remaining 18 percent (50% to 32%) who would
also be expected to have the disease would have necessitated
some other study (such as, gene linkage) to establish the
diagnosis. Nevertheless, ultrasonography most likely estab-
lished the diagnosis of ADPKD in childhood in approximately
two—thirds of the children (46 of estimated 77 patients, exclud-
ing three diagnosed by excretory urography) expected to ulti-
mately develop the disease. Moreover, the predictive accuracy
of ultrasonography may be even greater because not all of the
154 children had a known affected parent and thus the expected
frequency may have been less than 50 percent.
A linkage of the ADPKD gene to a marker on chromosome 16
has recently been identified [32]. However, use of this marker
requires a genetically informative family with three living
generations to be utilized. Moreover, the test is not commer-
cially available. Thus, it cannot be used as a routine screening
method in children considered at risk for ADPKD, and ultra-
sonography therefore remains the best available screening—
procedure for children in ADPKD families. The isolation of the
ADPKD gene itself will ultimately provide the diagnostic gold
standard.
In summary, 154 children 18 years or younger from 83
families with ADPKD were studied by ultrasonography or
excretory urography. A definite diagnosis of ADPKD was
established in 23 patients by demonstrating the presence of five
or more renal cysts and bilateral involvement. The presence of
renal cysts in another 24 children also made the diagnosis likely
since simple renal cysts are rare in children [28, 29]. The mean
kidney size in the 23 children with five or more renal cysts was
significantly larger than the other 131 children who also under-
went ultrasonography. Greater than 90 percent of these 23
children had hypertension, gross hematuria, a palpable abdom-
inal mass, or an abnormal urinalysis. In four children where
these symptoms and/or signs prompted the diagnosis before one
year of age, the prognosis was poor. The affected parents of
these four neonates, however, had stable renal function into the
third decade of life suggesting that this disease pattern is not
consistent within a family. In the remaining children diagnosed
after one year of age, the early prognosis on follow—up has been
relatively benign with stable renal function. Lastly, the use of
ultrasonography and careful history and physical examination
may allow for the diagnosis of approximately two-thirds of
ADPKD patients at the age of 18 years and under, thus
permitting early counseling and appropriate medical follow—up.
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